China · Delayed Price · Currency is CNY BeBetter Med Statistics
Total Valuation
BeBetter Med has a market cap or net worth of CNY 13.63 billion. The enterprise value is 12.11 billion.
| Market Cap | 13.63B |
| Enterprise Value | 12.11B |
Important Dates
The next estimated earnings date is Monday, June 29, 2026.
| Earnings Date | Jun 29, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BeBetter Med has 450.04 million shares outstanding.
| Current Share Class | 450.04M |
| Shares Outstanding | 450.04M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | -5.59% |
| Owned by Insiders (%) | 50.03% |
| Owned by Institutions (%) | 19.50% |
| Float | 178.58M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 8.38 |
| P/TBV Ratio | 8.58 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 31.91, with a Debt / Equity ratio of 0.00.
| Current Ratio | 31.91 |
| Quick Ratio | 30.86 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.02 |
| Interest Coverage | -2,564.01 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -12.14% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | -1.07M |
| Employee Count | 160 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, BeBetter Med has paid 120,517 in taxes.
| Income Tax | 120,517 |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 35.35 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 37.57 |
| Average Volume (20 Days) | 4,113,648 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -197.67M |
| Pretax Income | -170.38M |
| Net Income | -170.50M |
| EBITDA | -189.88M |
| EBIT | -197.67M |
| Earnings Per Share (EPS) | -0.42 |
Balance Sheet
The company has 1.52 billion in cash and 3.83 million in debt, with a net cash position of 1.52 billion or 3.37 per share.
| Cash & Cash Equivalents | 1.52B |
| Total Debt | 3.83M |
| Net Cash | 1.52B |
| Net Cash Per Share | 3.37 |
| Equity (Book Value) | 1.63B |
| Book Value Per Share | 3.61 |
| Working Capital | 1.53B |
Cash Flow
In the last 12 months, operating cash flow was -127.53 million and capital expenditures -26.62 million, giving a free cash flow of -154.15 million.
| Operating Cash Flow | -127.53M |
| Capital Expenditures | -26.62M |
| Depreciation & Amortization | 7.80M |
| Net Borrowing | -22.20M |
| Free Cash Flow | -154.15M |
| FCF Per Share | -0.34 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
BeBetter Med does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -1.25% |
| FCF Yield | -1.13% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |